SPY311.36-0.82 -0.26%
DIA263.33+0.16 0.06%
IXIC9,615.81-67.10 -0.69%
News
NVRO
--
0.00%
--
Why Is Nevro (NVRO) Up 7.1% Since Last Earnings Report?
Nevro (NVRO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks · 15h ago
New CFO at Nevro
Seeking Alpha - Article · 16h ago
Nevro Appoints Finance Executive Roderick MacLeod As Chief Financial Officer
Benzinga · 19h ago
Nevro Appoints Finance Executive Roderick MacLeod as Chief Financial Officer
Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced the appointment of Roderick ("Rod") MacLeod as Chief Financial Officer, effective June 15, 2020,
PR Newswire · 19h ago
Here's Why You Should Hold on to Nevro (NVRO) Stock Now
Zacks · 05/27 11:24
Nevro's (NVRO) Senza Omnia SCS System Gets CE Mark Approval
Zacks · 05/18 11:59
Nevro Reports CE Mark Approval Of Senza Omnia Spinal Cord Stimulation System To Treat Chronic Pain
Nevro Corp. (NYSE:NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced it has received CE mark approval for the Senza®
Benzinga · 05/14 11:17
Nevro Announces CE Mark Approval of Senza® Omnia™ Spinal Cord Stimulation System to Treat Chronic Pain
Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced it has received CE mark approval for the Senza® Omnia™ Spinal Cord Stimulation (SCS) system.
PR Newswire · 05/14 11:00
Nevro (NVRO) Earnings and Revenues Beat Estimates in Q1
Zacks · 05/07 14:14
SunTrust Robinson Humphrey Maintains Buy on Nevro, Raises Price Target of $135
SunTrust Robinson Humphrey maintains Nevro (NYSE:NVRO) with a Buy and raises the price target from $120 to $135.
Benzinga · 05/06 16:09
JP Morgan Maintains Neutral on Nevro, Raises Price Target to $100
JP Morgan maintains Nevro (NYSE:NVRO) with a Neutral and raises the price target from $90 to $100.
Benzinga · 05/06 14:19
Morgan Stanley Maintains Overweight on Nevro, Raises Price Target to $135
Morgan Stanley maintains Nevro (NYSE:NVRO) with a Overweight and raises the price target from $113 to $135.
Benzinga · 05/06 13:02
Edited Transcript of NVRO earnings conference call or presentation 5-May-20 8:30pm GMT
Thomson Reuters StreetEvents · 05/06 07:26
Nevro Corp (NVRO) CEO Keith Grossman on Q1 2020 Results - Earnings Call Transcript
Seeking Alpha - Transcript · 05/06 04:42
Nevro (NVRO) Reports Q1 Loss, Tops Revenue Estimates
Nevro (NVRO) delivered earnings and revenue surprises of 24.27% and 0.98%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Zacks · 05/05 23:25
Nevro Corp. 2020 Q1 - Results - Earnings Call Presentation
Seeking Alpha - Article · 05/05 22:47
Nevro Q1 EPS $(0.780) Beats $(0.970) Estimate, Sales $87.467M Miss $89.460M Estimate
Nevro (NYSE:NVRO) reported quarterly losses of $(0.780) per share which beat the analyst consensus estimate of $(0.970) by 19.59 percent. This is a 36.07 percent increase over losses of $(1.220) per share from the same
Benzinga · 05/05 20:40
Nevro Q1 2020 Earnings Preview
Nevro (NYSE:NVRO) is scheduled to announce Q1 earnings results on Tuesday, May 5th, after market close. The consensus EPS Estimate is -$0.99 (+31.7% Y/Y) a
seekingalpha · 05/05 02:35
Will Nevro (NVRO) Report Negative Earnings Next Week? What You Should Know
Zacks · 04/28 17:33
Nevro to Report First Quarter 2020 Financial Results
PR Newswire · 04/21 12:00